REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K909. A total of 3 filers reported holding REGULUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $379,224 | -6.2% | 274,800 | -0.0% | 0.00% | 0.0% |
| Q2 2023 | $404,103 | +70.0% | 274,900 | -2.3% | 0.00% | 0.0% |
| Q1 2023 | $237,691 | -70.2% | 281,300 | -51.7% | 0.00% | -50.0% |
| Q4 2022 | $798,573 | -18.2% | 582,900 | +1.5% | 0.00% | 0.0% |
| Q3 2022 | $976,000 | -17.1% | 574,200 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $1,178,000 | – | 569,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 569,300 | $1,178,000 | 0.00% |
| SIMPLEX TRADING, LLC | 27,500 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |